Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/3971
標題: 評估光誘導顏色變化之螢光質做為生物感測器的可行性
Evaluation of photoinduced color changing fluorophore for a biosensor
作者: 林容至
Lin, Jung-Chih
關鍵字: 光動力治療
photodynamic therapy
紫質
光誘導質子轉移
生物標記
porphyrin
photoinduced proton transfer
biomarker
出版社: 生醫工程研究所
引用: 參考文獻 1. 王麗雅, 王順利, 氫鍵結與質子化對分子內電荷轉移化合物的影響, The Chinese Chem. SOC., Taipei, September. 2006 Vol. 64, No.3, pp.407~416 2. 高國益, Push-Pull(推-拉)Styryl 系統的激發態質子轉移及激發態去氫鍵化反應之研究,國立嘉義大學應用化學研究所, January, 2006 3. 謝嘉民、賴一凡、林永昌、枋志堯,光激發螢光量測的原理、架構及應用,奈米通訊 第十二卷第二期, p35-43 4. R.V. BergassonJori, E. J. Land and T. G. Truscott.G., The historical development of ideas on applications of photosensitised reactions in health sciences. In Primary Photoprocesses in Biology and Medicine. 1985, pp. 209– 227. 5. EpsteinM. J., N.Engl., Phototherapy and photochemotherapy., J. Med. 1990, 32, 1149–1151. 6. CauvinF.J. Des bienfaits de l’insolation. University of Paris, France. , 1815. 7. Ron Allison Moghissi, Gordon Downie, Kate Dixon BA, Keyvan., Photodynamic therapy (PDT) for lung cancer. Photodiagnosis and Photodynamic Therapy, REVIEW. 2011, 8, 231—239. 8. Dennis E.J.G.J. DolmansFukumura and Rakesh K. JainDai. Photodynamic therapy for cancer, Nature publishing group. 2003, 3, 380-387 9. Stanley B Brown, Elizabeth A Brown, Ian Walker, The present and future role of photodynamic therapy in cancer treatment, Photodynamic therapy. 2004, Volume 5, Issue 8, Pages 497-508. 10. Moan, Berg, K.J., The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen, Photochem. Photobiol. 1991, 53, 549–553. 11. Maria C. DeRosaJ. CrutchleyRobert. Photosensitized singlet oxygen and its applications, Coordination Chemistry Reviews 233/234, 2002, 351-371. . 12. Thierry Patrice C. E. Moor, Bernhard Ortel and Tayyaba HasanAnne. Mechanisms of photodynamic therapy, Photodynamic Therapy. 2003, chapter 2. 13. Sharman M.W., Allen M.C., Van LierE.J. Photodynamic therapeutics: basic principles and clinical applications, Drug Discovery Today. 1999, 4, 507-517. 14. Michael R. DettyL. Gibson, and Stephen J. Wagner.*Scott. Current Clinical and Preclinical Photosensitizers for Use in Photodynamic Therapy. Journal of Medicinal Chemistry. 2004, Vol. 47, No. 16. 15. Osterloh J., VicenteG. H. J.M. Mechanisms of porphyrinoid localization in tumors. Porphyrins Phthalocyanines, 2002, 6, 305–324. 16. Vicente, M. G. H. Curr. Med. Chem., Anticancer Agents 2001, 1, 175–194. 17. Marzilli, L. G. New J. Chem. 1990, 14, 409–420. 18. Pratviel, G., Bernadou, J., Meunier, B. Angew. Chem. Int. Ed. Engl. 1995, 34, 746–769. 19. Bustamante, C., Gurrieri, S., Pasternack, R. F., Purrello, R., Rizzarelli, E. Biopolymers 1994, 34, 1099–1104. 20. Magda, D., Wright, M., Crofts, S., Lin, A., Sessler, J. L. J. Am. Chem. Soc. 1997, 119, 6947–6948. 21. Cheng-Chung Chang, I-Chun Kuo, Jing-Jer Lin, Yu-Cheng Lu, Chin-Tin Chen, Hong-Tsun Back, Pei-Jen Lou, Ta-Chau Chang, A novel carbazole derivative, BMVC: a potential antitumor agent and fluorescence marker of cancer cells., Chem Biodivers. 2004, 1, 1377-84. 22. Forster T. Zwischenmolekulare Energiewanderung und Fluoreszenz., Annalen der Physik. 1948, 437(1-2), 55-75. 23. EpeSteinhouser, K. G., Woolley, P.B., Theory of measurement of Forster-type energy transfer in macromolecules, Nation Academy of Sciences of the United States of America. 1983, 80(9), 2579-2583 24. Clegg.M.R. Fluorescence resonance energy transfer, Current Opinion in Biotechnology. 1995, 6(1), 103-110. 25. DietrichBuschmann, V., M ler, C., Sauer, M.A., Fluorescence resonance energy transfer(FRET) and competing processces in donor-acceptor substitued DNA strands:a comparative study of ensemble and single-molecule data., Reviews in Molecular Biotechnology. 2002, 82(3), 211-231. 26. Chi-Chih KangChang, Ji-Yen Cheng, Ta-Chau ChangCheng-Chung., Simple Method in Diagnosing Cancer Cells by a Novel Fluorescence., Journal of the Chinese Chemical Society, 2005, 52, 1069-1072. 27. D. KesselLuo.Y., Mitochondrial photodamage and PDT- meminduced apoptosis, J. Photochem. Photobiol. B: Biol., 42 (1998) 89–95. 28. Myriam E. Rodriguez, Junhwan Kim, Grace B. Delos Santos, Jeffrey Berlin, Vernon E. Anderson, Binding to and photo-oxidation of cardiolipin by the phthalocyanine photosensitizer Pc 4, Journal of Biomedical Optics 155, 051604 September/October 2010 29. Yi-Ping Fang, Hsien-Ting Cheng, 5-Aminolevulinic Acid-Loaded Gel, Sponge Collagen to Enhance the Delivery Ability to Skin, World Academy of Science, Engineering and Technology 66, 2012 30. J. Morgan Potter, A.R. Oseroff W.R., Comparison of photodynamic targets in a carcinoma cell line and its mitochondrial DNA-deficient derivative, Photochem. Photobiol.71 (2000) 747–757. 31. Janet Morgan R., Oseroff Allan., Mitochondria-based photodynamic anti-cancer therapy. Advanced Drug Delivery Reviews, 49 (2001) 71–86. 32. R. HilfMurant, U. Narayanan, S.L. GibsonR.S., Relationship of mitochondrial function and cellular adenosine triphosphate to hematoporphyrin derivative-induced photosensitization in AC mammary tumors., Cancer Res. 46 (1986) 211–217. 33. AtlanteMoreno, S. Passarella, C. SaletG., Hematoporphyrin derivative (Photofrin II) photosensitization of isolated mitochondria: impairment of anion translocation., Biochem. Biophys. Res. Commun. 141 (1986) 584–590. 34. B. SaletMoreno, F. VinzensG., Effects of Photodynamic action on energy coupling of Ca21 uptake in liver mitochondrial, Biochem. Biophys. Res. Commun. 115 (1983) 76–81. 35. C. SaletMorenoG., Photodynamic action increases leakage of the mitochondrial electron transport chain, Int. J. Radiat.Biol. 67 (1995) 477–480. 36. A. AtlantePassarella, E. QuagliarielloS., Haematoporphyrin derivative (Photofrin II) photosensitization of isolated mitocchondria., J. Photochem Photobiol. B: Biol. 4 (1989) 35–46. 37. D. KesselLuoY., Photodynamic therapy: a mitochondrial inducer of apoptosis, Cell Death Differ., 6 (1999) 28–35. 38. D.G. GranvilleCarthy, H. Jiang, G.C. Shore, B.M. McManus, D.W.C. HuntC.M., Rapid cytochrome c release, activation of caspases 3, 6,7 and 8 followed by Bap31 cleavage in HeLa cells treated with photodynamic therapy., FEBS Lett. 437 (1998) 5–10. 39. Nagata SA, Gohto Y, Nakajima S.Obana., Necrotic and apoptotic cell death of human malignant melanoma cells following photodynamic therapy using an amphiphilic photosensitizer ATX-S10(Na)., Lasers Surg Med. 2003;33:64—70 40. D. KesselLuo, Y. Deng, C.K. ChangY., The role of subcellular localization in initiation of apoptosis by photo- dynamic therapy. Photochem. Photobiol. 65 (1997) 442–446 41. D. KesselLuoY., Mitochondrial photodamage and PDT- meminduced apoptosis, J. Photochem. Photobiol. B: Biol. 42 (1998) 89–95. 42. J. DahleSteen, J. Moan .H.B., The mode of cell death induced by photodynamic treatment depends on cell density, Photochem. Photobiol. 1999, 70, 363-367. 43. D.J. GranvilleLevy, D.W. Hunt .J.G., Photodynamic therapy induces caspase-3 activation in HL-60 cells, Cell Death Difl. 1997, 4, 623-629. 44. M. AmbrozMacRobert, J. Morgan, G. Rumbles, M.S.C. Foley, D. PhillipsA.J. (22(1994) 105–117). Time-resolved fluorescence spectroscopy and intracellular imaging of disulphonated aluminium phthalocyanine. J. Photochem. Photobiol. B: Biol. 45. Mataga N, Kaifu Y, Koizumi M., Solvent effect uponfluorescence spectra and the dipole moment of the excited molecules., Bull Chem Soc Jpn, 1956, 29, 465-470 46. Lakowicz, Joseph R., Solvent and environment effect., Principles of Fluorescence Spectroscopy, 2006, chapter 6, p205-235 47. Shun-Li Wang, Guo-Yi Gao, Tong-Ing Ho, Li-Yu Yang, Excited-state proton transfer and excited-state de-hydrogen bonding of the push–pull styryl system., 2005, Chemical Physics Letters 415 ,217–222 48. Shun-Li Wang, Tong-Ing Ho, Protonation dependent electron transfer in 2-styrylquinolines, Chemical Physics Letters 268 (1997) 434-438 49. Mergens, William J., Efficacy of vitamin E to prevent nitrosamine formation., Annals New York Academy of Sciences, 1982,p61-69 50. Anthony J. A. Ouellette, Lorraine B. Anderson, and Bridgette A. Barry., Amine binding and oxidation at the catalytic site for photosynthetic water oxidation., Biochemistry, Vol. 95, pp. 2204–2209, March 1998 51. Chung S. Yang, Shih-Hsin Lu., Effect of nutrition on carcinogenesis: Mechanisms involes nitrosamines., Nutrients and cancer prevention, 1990 52. R.Margabandu, K.Subramani., Prediction of ionization constant (pka) ofsubstituted aniline by semi-empirical calculation., Department of Chemistry, Islamiah College, Vaniyambadi, PIN- 635751, Tamil Nadu.India. 53. V. V. Moroz, A. G. Chalyi, and A. D. Roshal., The Properties of 4''-N,N-Dimethylaminoflavonol in the Ground and Excited States., Russian Journal of Physial Chemistry A, 2008,Vol. 82, No. 9 54. Shun-Li Wang, Tong-Ing Ho., Protonation dependent electron transfer in 2-styrylquinolines., Chemical Physics Letters, 268 (1997) 434-438 55. Nicole Fehrenbacher, Marja Ja‥a‥ttela., Lysosomes as Targets for Cancer Therapy, Cancer Research, 2005; 65: (8). April 15, 2005 56. Dale Sanders, Ulf-Peter Hansan, Clifford L. Slayman, Role of the plasma membrane proton pump in pH regulation in non-animal cell, Physiological Science, Vol. 78, No. 9, pp. 5903-5907, September 1981 57. J.R. Griffiths, Are cancer cells acidic? Br. J. Cancer (1991), 64, 425-427 58. Peter Vaupel, Friedrich Kallinowski, and Paul Okunieff, Blood Flow, Oxygen and Nutrient Supply, and Metabolic Microenvironment of Human Tumors: A Review, CANCER RESEARCH 49, 6449-6465. December 1, 1989.
摘要: 本研究中主要著重於對癌症的治療及檢測,實驗中我們利用3,6-bis[2-(1-methylpyridinium)vinyl]carbazole diiodide (BMVC)和porphyrin形成一個複合分子,成為光動力治療 (Photodynamic therapy, PDT)的二元系統,在系統中利用BMVC的螢光產生螢光共振能量轉移 (Fluorescence resonance energy transfer, FRET)至porphyrin,以提升porphyrin的PDT效果,並在PDT照光過程中發現細胞隨著照光產生螢光的變化,照光後細胞死亡並伴隨著細胞核逐漸產生亮綠色螢光,故在此二元系統中成功利用BMVC螢光產生FRET至porphyrin分子,光感物質porphyrin產生PDT殺死癌細胞,同時可做為一個細胞死亡的生物標記。鑑於細胞螢光變化的重要性,發現化合物2-(6-(4-aniline)-1,3-dioxo-1H-benzo[de]isoquinolin- 2(3H)-yl)-N,N-dimethylethanamine (ADA)於細胞內亦會照光產生細胞內螢光變化,除此之外觀察到ADA分子可利用螢光強度辨識正常細胞,期許ADA可做為標記正常細胞的螢光分子,在研究中發現ADA會產生激發態質子轉移的反應,以產生螢光光譜藍位移 (blue shift)並增強的變化,並且對於pH 具有敏感性,加酸後產生螢光下降,由於此特性,推測產生細胞內螢光強度不同的現象,為正常細胞與癌細胞中酸鹼度的差異性,此特性可應用在做癌症檢測時的控制組,預計算癌細胞於組織中的比例時,此螢光分子可作為計算中的分母,對於癌症檢測中提供醫生準確數字以達到更完善的癌症治療。
In this study, we focused on the therapy and diagnosis of cancers. Three binary molecule conjugates were designed and synthesized by conjugating a chromophore (3,6-bis-(1-methyl-4-vinylpyridinium)-carbazole diiodide, BMVC) to mono-, bis- and trishydroxyl photosensitizers, respectively. For this binary system, BMVC plays the role of cancer cells recognizer; fluorescence resonance energy transfer (FRET) donor to porphyrins, and also enhance the efficient of photodynamic therapy (PDT). In addition, the intracellular fluorescent colors switching upon photo-excitation are expected to be used for further cell death biomarker applications. Therefore the binary system was successful to apply the FRET effect to PDT, also killed the cancer cells selectively.Base on the study above, fluorescent color switching in cells is important for cancer cell recognization. Here, a pH-dependent fluorescence emission compound, 2-(6-(4-aniline)-1, 3-dioxo-1-H-benzo [de]isoquinolin -2(3H)-yl)-N,N-dimethyl-ethanamine (ADA), was designed and we investigated the excited state proton transfer (ESPT) behaviour when irradiation. The fluorescent intensity quenched once the compound ADA was protonated while irradiation resulted in emission blue-shift and intensity enhancement due to the ESPT. When cells were treated with ADA, the fluorescent intensity in normal cells is much higher than cancer cells due to their different degree of pH environment. On the other hand, intracellular fluorescent colors switching upon irradiatting. It hints that ADA is expected to become a normal cell biomarker as well as the control brackground in calculation the percentage of cancer cells in whole tissue.
URI: http://hdl.handle.net/11455/3971
其他識別: U0005-1608201220012800
文章連結: http://www.airitilibrary.com/Publication/alDetailedMesh1?DocID=U0005-1608201220012800
Appears in Collections:生醫工程研究所

文件中的檔案:

取得全文請前往華藝線上圖書館



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.